Quantitative longitudinal T2* mapping for assessing placental function and association with adverse pregnancy outcomes across gestation

Authors:

Abstract
Existing methods for evaluating in vivo placental function fail to reliably detect pregnancies at-risk for adverse outcomes prior to maternal and/or fetal morbidity. Here we report the results of a prospective dual-site longitudinal clinical study of quantitative placental T2* as measured by blood oxygen-level dependent magnetic resonance imaging (BOLD-MRI). The objectives of this study were: 1) to quantify placental T2* at multiple time points across gestation, and its consistency across sites, and 2) to investigate the association between placental T2* and adverse outcomes. 797 successful imaging studies, at up to three time points between 11 and 38 weeks of gestation, were completed in 316 pregnancies. Outcomes were stratified into three groups: (UN) uncomplicated/normal pregnancy, (PA) primary adverse pregnancy, which included hypertensive disorders of pregnancy, birthweight Trial registration: ClinicalTrials.gov: NCT02749851.
Funding Information
  • National Institute of Child Health and Development Human Placenta Project (U01 HD 087182)
  • National Institute of Child Health and Development Human Placenta Project (R01 HD 086331)
  • National Institutes of Health (S10OD021701)
  • National Institutes of Health (S10OD018224)
  • Oregon Clinical & Translational Research Institute grant which supported the use of REDCap (Research Electronic Data Capture) for data abstraction (UL1TR002369)

This publication has 59 references indexed in Scilit: